FDA authorizes Pfizer COVID vaccine booster for children 5 to 11
Published
FDA authorized the Pfizer-BioNTech COVID booster for children aged 5 to 11 five months after they have finished the first two-shot vaccination series.
Published
FDA authorized the Pfizer-BioNTech COVID booster for children aged 5 to 11 five months after they have finished the first two-shot vaccination series.
Watch VideoThree doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced..
Watch VideoU.S. regulators on Tuesday authorized a COVID-19 booster shot for healthy 5- to 11-year-olds, hoping an extra vaccine..